Stock Detail
NEUROMETRIX INC
Sector: Medical Instruments Supls
Latest Quote @ Sat May 5 10:59:49 (15 min delayed)
| N/A |
N/A |
$1.91 |
-0.03 |
-1.55% |
|
Last Day's Data
| $1.91 |
$1.94 |
$0.00 |
0.00% |
0.00 |
$1.94 |
| $1.92 |
$1.90 |
6,097.00 |
4.14M |
14,968.00 |
0.00 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 1.96 |
1.94 |
1.92 |
1.90 |
1.88 |
Stock Profile
NeuroMetrix, Inc., a medical device company, engages in the design, development, and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or are associated with diabetes, low back pain, and carpal tunnel syndrome, as well as other clinical disorders. The company offers NC-stat System, a neuropathy diagnostic system that provides physicians the ability to diagnose patients with neuropathies at the point-of-service. The system comprises disposable NC-stat biosensors; the NC-stat monitor and related components; and the NC-stat docking station, an optional device that enables the physician to transmit data to the company's onCall Information System. NeuroMetrix also has products under development, such as devices for the treatment of neuropathy, new NC-stat biosensors and associated software for the medically appropriate testing of additional nerves, and third generation NC-stat monitor and docking station. As of April 27, 2005, the NC-stat System was used in approximately 2,400 physician's offices, clinics, and other health care facilities. The company markets its products through regional sales managers and independent regional sales agencies to physicians in the United States. NEUROMetrix was founded by Shai N. Gozani in 1996 and is headquartered in Waltham, Massachusetts.
